cetylpyridinium chloride anhydrous has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kannan, Y; Kitagawa, H; Takeuchi, T; Tsukahara, S; Yokoyama, T | 1 |
| Ben-David, Y; Gajendran, B; Liu, W; Sample, KM; Varier, KM; Zacksenhaus, E | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and losartan potassium
| Article | Year |
|---|---|
Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
Topics: Erythropoiesis; Erythropoietin; Health; Humans; Neoplasms; Receptors, Erythropoietin; Signal Transduction; Tumor Microenvironment | 2020 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and losartan potassium
| Article | Year |
|---|---|
No apoptotic cell death of erythroid cells of erythroblastic islands in bone marrow of healthy rats.
Topics: Animals; Apoptosis; Erythroblasts; Erythropoiesis; Erythropoietin; Health; Male; Rats; Rats, Wistar | 2002 |